Company Analysis Kingworld Medicines Group Limited
1. Summary
Advantages
- Price (0.56 HK$) is less than fair price (0.5922 HK$)
- The stock's return over the last year (5.66%) is higher than the sector average (0%).
- The company's current efficiency (ROE=6.17%) is higher than the sector average (ROE=4.24%)
Disadvantages
- Dividends (4.26%) are below the sector average (5.6%).
- Current debt level 21.73% has increased over 5 years from 20.19%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Kingworld Medicines Group Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | 0% | 0.4% |
| 90 days | 27.3% | -39.3% | -0.3% |
| 1 year | 5.7% | 0% | 31.9% |
1110 vs Sector: Kingworld Medicines Group Limited has outperformed the "Healthcare" sector by 5.66% over the past year.
1110 vs Market: Kingworld Medicines Group Limited has significantly underperformed the market by -26.25% over the past year.
Stable price: 1110 is not significantly more volatile than the rest of the market on "Hong Kong Exchanges" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 1110 with weekly volatility of 0.1089% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (0.56 HK$) is lower than the fair price (0.5922 HK$).
Price not significantly lower than the fair price: The current price (0.56 HK$) is slightly lower than the fair price by 5.7%.
4.2. P/E
P/E vs Sector: The company's P/E (9.85) is lower than that of the sector as a whole (31.87).
P/E vs Market: The company's P/E (9.85) is lower than that of the market as a whole (26.88).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.5367) is lower than that of the sector as a whole (2.54).
P/BV vs Market: The company's P/BV (0.5367) is lower than that of the market as a whole (1.66).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.348) is lower than that of the sector as a whole (6.25).
P/S vs Market: The company's P/S indicator (0.348) is lower than that of the market as a whole (2.66).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (4.52) is higher than that of the sector as a whole (2.91).
EV/Ebitda vs Market: The company's EV/Ebitda (4.52) is lower than that of the market as a whole (9.93).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 45.03% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (45.03%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-25.07%).
5.4. ROE
ROE vs Sector: The company's ROE (6.17%) is higher than that of the sector as a whole (4.24%).
ROE vs Market: The company's ROE (6.17%) is higher than that of the market as a whole (3.92%).
5.5. ROA
ROA vs Sector: The company's ROA (2.93%) is lower than that of the sector as a whole (3.29%).
ROA vs Market: The company's ROA (2.93%) is lower than that of the market as a whole (3.34%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 4.26% is below the average for the sector '5.6%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 4.26% has been steadily paid over the past 7 years, DSI=0.93.
Weak dividend growth: The company's dividend yield 4.26% has been growing weakly or stagnant over the past 5 years. Growth over only 3 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (36.54%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
